GlaxoSmithKline HPV vaccine (GSK-580299)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GlaxoSmithKline HPV vaccine (GSK-580299), covering 2016-03-28 to 2016-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females [Phase 3]